Cohort
|
Variable, score or titres
|
DAS28
|
CRP
|
RF
|
ACPA
|
---|
A
|
DAS28
| | | |
Pearson product–moment correlation (r)
|
|
CRP
|
0.12
| | | |
|
RF
|
0.22
|
-0.13
| | |
|
ACPA
|
-0.14
|
0.20
|
0.27
| |
|
14-3-3η
|
0.18
|
0.20
|
0.43b
|
0.31c
|
B
|
|
DAS28
| | | |
Pearson product–moment correlation (r)
|
|
CRP
|
0.46d
| | | |
|
RF
|
-0.06
|
-0.02
| | |
|
ACPA
|
-0.17
|
-0.14
|
0.17
| |
|
14-3-3η
|
-0.03
|
-0.09
|
0.03
|
-0.07
|
- aACPA, Anticitrullinated protein antibody; CRP, C-reactive protein DAS28: Disease Activity Score in 28 joints; RF: rheumatoid factor. bP < 0.01; cP ≤ 0.05; dP < 0.001. Cohort A is the University of Sherbrooke early rheumatoid arthritis cohort at the baseline time point (n = 33). Cohort B is the Behandel Strategieën (BeSt) study cohort of patients with established RA at the year 3 time point (n = 40).